Literature DB >> 20382334

Mortality patterns of Army Chemical Corps veterans who were occupationally exposed to herbicides in Vietnam.

Yasmin Cypel1, Han Kang.   

Abstract

PURPOSE: This research examined the risk of disease-related mortality of the Army Chemical Corps (ACC) veterans who handled/sprayed herbicides in Vietnam in comparison with their non-Vietnam veteran peers or U.S. men.
METHODS: Vital status was determined through December 31, 2005. All-cause mortality and cause-specific mortality were compared for individuals who served in Vietnam (n = 2872) versus those who did not (n = 2737). Similar analyses were completed on a subset of the original Vietnam cohort that consisted of individuals who either reported spraying herbicide (n = 662) or not (n = 811). The observed deaths for each of the two base cohorts were also compared with expected deaths for U.S. men.
RESULTS: Statistically significant excess mortality was found for ACC Vietnam veterans for chronic obstructive pulmonary disease (adjusted relative risk [ARR], 4.82; 95% confidence interval [95% CI], 1.10-21.18). When examining patterns for veterans in the Vietnam veteran subset, we found nonsignificant elevated ARRs among herbicide sprayers for all-cause, respiratory system disease, and respiratory system cancer mortality. Compared with U.S. men, the Vietnam veteran cohort had significant excess mortality for all-causes (standardized mortality ratio [SMR], 1.13; 95% CI, 1.04-1.23), respiratory system cancer (SMR, 1.35; 95% CI, 1.03-1.73), nonmalignant respiratory system disease (SMR, 1.58; 95% CI, 1.08-2.23), and miscellaneous malignant cancers (SMR, 1.77; 95% CI, 1.03-2.84).
CONCLUSIONS: The risk of mortality from respiratory disease (malignant or nonmalignant) was significantly greater for ACC Vietnam veterans in comparison with their non-Vietnam veteran peers and U.S. men. Herbicide exposure could be contributing to the patterns observed. Because of the unique nature of their military duties and study limitations, findings may not be generalizeable to Vietnam veterans as a whole. Published by Elsevier Inc.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20382334     DOI: 10.1016/j.annepidem.2010.02.003

Source DB:  PubMed          Journal:  Ann Epidemiol        ISSN: 1047-2797            Impact factor:   3.797


  7 in total

Review 1.  Dioxins: diagnostic and prognostic challenges arising from complex mechanisms.

Authors:  Noel M Rysavy; Kristina Maaetoft-Udsen; Helen Turner
Journal:  J Appl Toxicol       Date:  2012-05-19       Impact factor: 3.446

Review 2.  A critical review of the epidemiology of Agent Orange/TCDD and prostate cancer.

Authors:  Ellen T Chang; Paolo Boffetta; Hans-Olov Adami; Philip Cole; Jack S Mandel
Journal:  Eur J Epidemiol       Date:  2014-07-27       Impact factor: 8.082

3.  TCDD and cancer: a critical review of epidemiologic studies.

Authors:  Paolo Boffetta; Kenneth A Mundt; Hans-Olov Adami; Philip Cole; Jack S Mandel
Journal:  Crit Rev Toxicol       Date:  2011-07-01       Impact factor: 5.635

Review 4.  Prostate cancer in firefighting and police work: a systematic review and meta-analysis of epidemiologic studies.

Authors:  Jeavana Sritharan; Manisha Pahwa; Paul A Demers; Shelley A Harris; Donald C Cole; Marie-Elise Parent
Journal:  Environ Health       Date:  2017-11-17       Impact factor: 5.984

5.  Real-Time Measurement of Herbicides in the Atmosphere: A Case Study of MCPA and 2,4-D during Field Application.

Authors:  Trey Murschell; Delphine K Farmer
Journal:  Toxics       Date:  2019-08-06

Review 6.  Research on the Relationship between Exposure to Dioxins and Cancer Incidence in Vietnam.

Authors:  Tuong Phi Vuong
Journal:  Toxics       Date:  2022-07-11

Review 7.  Occupational Exposures and Environmental Health Hazards of Military Personnel.

Authors:  Marta Geretto; Marco Ferrari; Roberta De Angelis; Filippo Crociata; Nicola Sebastiani; Alessandra Pulliero; William Au; Alberto Izzotti
Journal:  Int J Environ Res Public Health       Date:  2021-05-18       Impact factor: 3.390

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.